Hematoma removal, heme, and heme oxygenase following hemorrhagic stroke

Annals of the New York Academy of Sciences

Volumn 1012, Issue , 2004, Pages 237-251

  Wagner, Kenneth R ^a,d   Dwyer, Barney E ^b,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VA MEDICAL CENTER   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Brain hemorrhage; Heme; Heme oxygenase; Oxidative stress; Stroke

Indexed keywords

BILIVERDIN; HEME; HEME OXYGENASE; HEME OXYGENASE INHIBITOR; METALLOPORPHYRIN; OXIDOREDUCTASE;

ANTIOXIDANT ACTIVITY; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN VASOSPASM; CENTRAL NERVOUS SYSTEM DISEASE; DISEASE CLASSIFICATION; EXPERIMENTAL MODEL; HEMOLYSIS; HEMORRHAGIC STROKE; HUMAN; MORBIDITY; MORTALITY; NEUROPROTECTION; OUTCOMES RESEARCH; OXIDATIVE STRESS; REVIEW; SIDEROSIS; STROKE; SUBARACHNOID HEMORRHAGE;

EID: 1842556541     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1306.020     Document Type: Review

References (95)

1. QURESHI, A.I., S. TUHRIM, J.P. BRODERICK et al. 2001. Spontaneous intracerebral hemorrhage. N. Engl. J. Med. 344: 1450-1460.
2. WOO, D. & J.P. BRODERICK. 2002. Spontaneous intracerebral hemorrhage: epidemiology and clinical presentation. Neurosurg. Clin. N. Am. 13: 265-279.
3. THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE RT-PA STROKE STUDY GROUP. 1995. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333: 1581-1587.
4. SUZUKI, J. & T. EBINA. 1980. Sequential changes in tissue surrounding ICH. In Spontaneous Intracerebral Hematomas, pp. 121-128. Springer-Verlag. Berlin.
5. MENOELOW, A.D. 1993. Mechanisms of ischemic brain damage with intracerebral hemorrhage. Stroke 24: 1115-1117.
6. KOEPPEN, A.M., A.C. DICKSON & J.A. MCEVOY. 1995. The cellular reactions to experimental intracerebral hemorrhage. J. Neurol Sci. 134(suppl.): 102-112.
7. XI, G., K.R. WAGNER, R.F. KEEP et al. 1998. Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke 29: 2580-2586.
8. WAGNER, K.R. & J.P. BRODERICK. 2001. Hemorrhagic stroke: pathophysiological mechanisms and neuroprotective treatments. In Neuroprotection, pp. 471-508. Prominent Press. Scottsdale, AZ.
9. XI, G., R.F. KEEP & J.T. HOFF. 2002. Pathophysiology of brain edema formation. Neurosurg. Clin. N. Am. 13: 371-383.
10. XI, G., G. REISER & R.F. KEEP. 2003. The role of thrombin and thrombin receptors in ischemic, hemorrhagic, and traumatic brain injury: deleterious or protective? J. Neurochem. 84: 3-9.
11. WAGNER, K.R., F.R. SHARP, T.D. ARDIZZONE et al. 2003. Heme and iron metabolism: role in cerebral hemorrhage. J. Cereb. Blood Flow Metab. 23: 629-652.
12. FAYAD, P.B. & I.A. AWAD. 1998. Surgery for intracerebral hemorrhage. Neurology 51: 69-73.
13. ZUCCARELLO, M., N. ANDALUZ & K.R. WAGNER. 2002. Minimally invasive therapy for intracerebral hematomas. Neurosurg. Clin. N. Am. 13: 349-354.
14. BRADLEY, W.O., JR. 1993. MR appearance of hemorrhage in the brain. Radiology 189: 15-26.
15. ATLAS, S.W. & K.R. THULBORN. 1998. MR detection of hyperacute parenchymal hemorrhage of the brain. Am. J. Neuroradiol. 19: 1471-1477.
16. LETARTE, P.B., K. LIEBERMAN, K. NAGATANI et al. 1993. Hemin: levels in experimental subarachnoid hematoma and effects on dissociated vascular smooth-muscle cells. J. Neurosurg. 79: 252-255.
17. DARROW, V.C., E.C. ALVORD, JR., L.A. MACK et al. 1988. Histologic evolution of the reactions to hemorrhage in the premature human infant's brain: a combined ultrasound and autopsy study and a comparison with the reaction in adults. Am. J. Pathol. 130: 44-58.
18. XI, G., R.F. KEEP & J.T. HOFF. 1998. Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J. Neurosurg. 89: 991-996.
19. MACDONALD, R.L. & B.K. WEIR. 1991. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22: 971-982.
20. MARLET, J.M. & J.P. BARRETO FONSECA. 1982. Experimental determination of time of intracranial hemorrhage by spectrophotometric analysis of cerebrospinal fluid. J. Forensic Sci. 27: 880-888.
21. WAGNER, K.R., G. XI, Y. HUA et al. 1996. Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter. Stroke 27: 490-497.
22. ANDALUZ, N., M. ZUCCARELLO & K.R. WAGNER. 2002. Experimental animal models of intracerebral hemorrhage. Neurosurg. Clin. N. Am. 13: 385-393.
23. HUA, Y., G. XI, R.F. KEEP et al. 2000. Complement activation in the brain after experimental intracerebral hemorrhage. J. Neurosurg. 92: 1016-1022.
24. MATZ, P.G., P.R. WEINSTEIN & F.R. SHARP. 1997. Heme oxygenase-1 and heat shock protein 70 induction in glia and neurons throughout rat brain after experimental intracerebral hemorrhage. Neurosurgery 40: 152-160.
25. SADRZAOEH, S.M., D.K. ANDERSON, S.S. PANTER et al. 1987. Hemoglobin potentiates central nervous system damage. J. Clin. Invest. 79: 662-664.
26. REGAN, R.F. & S.S. PANTER. 1993. Neurotoxicity of hemoglobin in cortical cell culture. Neurosci. Lett. 153: 219-222.
27. REGAN, R.F. & S.S. PANTER. 1996. Hemoglobin potentiates excitotoxic injury in cortical cell culture. J. Neurotrauma 13: 223-231.
28. TOLOSANO, E. & F. ALTRUDA. 2002. Hemopexin: structure, function, and regulation. DNA Cell Biol. 21: 297-306.
29. ORTIZ DE MONTELLANO, P.R. & A. WILKS. 2001. Heme oxygenase structure and mechanism. Adv. Inorg. Chem. 51: 359-405.
30. MAINES, M.D. 1997. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37: 517-554.
31. TRAKSHEL, G.M., R.K. KUTTY & M.D. MAINES. 1988. Resolution of the rat brain heme oxygenase activity: absence of a detectable amount of the inducible form (HO-1). Arch. Biochem. Biophys. 260: 732-739.
32. EWING, J.F., S.N. HABER & M.D. MAINES. 1992. Normal and heat-induced patterns of expression of heme oxygenase-1 (HSP32) in rat brain: hyperthermia causes rapid induction of mRNA and protein. J. Neurochem. 58: 1140-1149.
33. DWYER, B.E., R.N. NISHIMURA, J. DE VELLIS et al. 1992. Heme oxygenase is a heat shock protein and PEST protein in rat astroglial cells. Glia 5: 300-305.
34. DWYER, B.E., R.N. NISHIMURA, S.Y. Lu et al. 1996. Transient induction of heme oxygenase after cortical stab wound injury. Brain Res. Mol. Brain Res. 38: 251-259.
35. DWYER, B.E., S.Y. LU, J.T. LAITINEN et al. 1998. Protective properties of tin-and manganese-centered porphyrins against hydrogen peroxide-mediated injury in rat astroglial cells. J. Neurochem. 71: 2497-2504.
36. VERMA, A., D.J. HIRSCH, C.E. GLATT et al. 1993. Carbon monoxide: a putative neural messenger. Science 259: 381-384.
37. DWYER, B.E., R.N. NISHIMURA & S.Y. LU. 1995. Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody: response to oxidative stress. Brain Res. Mol. Brain Res. 30: 37-47.
38. DWYER, B.E., R.N. NISHIMURA & S.Y. LU. 1995. Differential localization of heme oxygenase and NADPH-diaphorase in spinal cord neurons. Neuroreport 6: 973-976.
39. WEBER, C.M., B.C. EKE & M.D. MAINES. 1994. Corticosterone regulates heme oxygenase-2 and NO synthase transcription and protein expression in rat brain. J. Neurochem. 63: 953-962.
40. RAJU, V.S., W.K. MCCOUBREY, JR. & M.D. MAINES. 1997. Regulation of heme oxygenase-2 by glucocorticoids in neonatal rat brain: characterization of a functional glucocorticoid response element. Biochim. Biophys. Acta 1351: 89-104.
41. DENNERY, P.A. 2000. Regulation and role of heme oxygenase in oxidative injury. Curr. Top. Cell. Regul. 36: 181-199.
42. LI, X. & J.D. CLARK. 2000. Chronic morphine exposure and the expression of heme oxygenase type 2. Mol. Brain Res. 75: 179-184.
43. GORDH, T., H.S. SHARMA, M. Azizi et al. 2000. Spinal nerve lesion induces upregulation of constitutive isoform of heme oxygenase in the spinal cord: an immunohistochemical investigation in the rat. Amino Acids 19: 373-381.
44. PANAHIAN, N. & M.D. MAINES. 2001. Site of injury-directed induction of heme oxygenase-1 and -2 in experimental spinal cord injury: differential functions in neuronal defense mechanisms? J. Neurochem. 76: 539-554.
45. MCCOUBREY, W.K., JR., T.J. HUANG & M.D. MAINES. 1997. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur. J. Biochem. 247: 725-732.
46. SCAPAGNINI, G., R. FORESTI, V. CALABRESE et al. 2002. Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol. Pharmacol. 61: 554-561.
47. MCDONAGH, A.F. 2001. Turning green to gold. Nat. Struct. Biol. 8: 198-200.
48. EWING, J.F., C.M. WEBER & M.D. MAINES. 1993. Biliverdin reductase is heat resistant and coexpressed with constitutive and heat shock forms of heme oxygenase in brain. J. Neurochem. 61: 1015-1023.
49. PANAHIAN, N., T. HUANG & M.D. MAINES. 1999. Enhanced neuronal expression of the oxidoreductase - biliverdin reductase - after permanent focal cerebral ischemia. Brain Res. 850: 1-13.
50. HORI, R., M. KASHIBA, T. TOMA et al. 2002. Gene transfection of H25A mutant heme oxygenase-1 protects cells against hydroperoxide-induced cytotoxicity. J. Biol. Chem. 277: 10712-10718.
51. MAINES, M.D. & N. PANAHIAN. 2001. The heme oxygenase system and cellular defense mechanisms. In From Genes to Bedside, pp. 249-272. Kluwer/Plenum. New York.
52. MAINES, M.D., J.F. EWING, T.J. HUANG et al. 2001. Nuclear localization of biliverdin reductase in the rat kidney: response to nephrotoxins that induce heme oxygenase-1. J. Pharmacol. Exp. Ther. 296: 1091-1097.
53. AHMAD, Z., M. SALIM & M.D. MAINES. 2002. Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress. J. Biol. Chem. 277: 9226-9232.
54. NAGAI, H., K. KITAGAKI, K. KUWABARA et al. 1992. Anti-inflammatory properties of zinc protoporphyrin disodium (Zn-PP-2Na). Agents Actions 37: 273-283.
55. NAGAI, H., Y. TAKAOKA, H. MORI et al. 1996. The effects of mesoporphyrin on experimental arthritis in mice. Inflammation Res. 45: 293-298.
56. KADOYA, C., E.F. DOMINO, G.Y. YANG et al. 1995. Preischemic, but not postischemic zinc protoporphyrin treatment reduces infarct size and edema accumulation after temporary focal cerebral ischemia in rats. Stroke 26: 1035-1038.
57. LIN, T.N., S.F. CHEN, H. LIN et al. 1999. Role of heme oxygenase-1 (HO-1) in cerebral ischemia-reperfusion. Soc. Neurosci. Abstr. 25(part 2): 1587.
58. PANIZZON, K.L., B.E. DWYER, R.N. NISHIMURA et al. 1996. Neuroprotection against CA1 injury with metalloporphyrins. Neuroreport 7: 662-666.
59. 2, and terminal mitochondrial electron transport. Kidney Int. 51: 728-738.
60. DA SILVA, J.L., T. MORISHITA, B. ESCALANTE et al. 1996. Dual role of heme oxygenase in epithelial cell injury: contrasting effects of short-term and long-term exposure to oxidant stress. J. Lab. Clin. Med. 128: 290-296.
61. WAGNER, K.R., Y. HUA et al. 2000. Tin-mesoporphyrin, a potent heme oxygenase inhibitor, for treatment of intracerebral hemorrhage: in vivo and in vitro studies. Cell. Mol. Biol. (Noisy-Le-Grand) 46: 597-608.
62. PEELING, J., H.J. YAN, S.O. CHEN et al. 1998. Protective effects of free radical inhibitors in intracerebral hemorrhage in rat. Brain Res. 795: 63-70.
63. PEELING, J., M.R. DEL BIGIO, D. CORBETT et al. 2001. Efficacy of disodium 4-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (NXY-059), a free radical trapping agent, in a rat model of hemorrhagic stroke. Neuropharmacology 40: 433-439.
64. WAGNER, K.R., B.A. PACKARD, C.L. HALL et al. 2002. Protein oxidation and heme oxygenase-1 induction in porcine white matter following intracerebral infusions of whole blood or plasma. Dev. Neurosci. 24: 154-160.
65. WU, J., Y. HUA, R.F. KEEP et al. 2002. Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage. Brain Res. 953: 45-52.
66. HUANG, F.P., G. XI, R.F. KEEP et al. 2002. Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J. Neurosurg. 96: 287-293.
67. KOEPPEN, A.H. & A.C. DICKSON. 2002. Tin-protoporphyrin prevents experimental superficial siderosis in rabbits. J. Neuropathol. Exp. Neurol. 61: 689-701.
68. TREGGIARI-VENZI, M.M., P.M. SUTER & J.A. ROMAND. 2001. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurgery 48: 249-261.
69. DUMONT, A.S., R.J. DUMONT, M.M. CHOW et al. 2003. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 53: 123-133.
70. VOLLMER, D.G., K. HONGO, H. OGAWA et al. 1991. A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm prophylaxis in a rabbit model of subarachnoid hemorrhage. Neurosurgery 28: 27-32.
71. ARTHUR, A.S., A.H. FERGUS, G. LANZINO et al. 1997. Systemic administration of the iron chelator deferiprone attenuates subarachnoid hemorrhage-induced cerebral vasospasm in the rabbit. Neurosurgery 41: 1385-1391.
72. HORKY, L.L., R.M. PLUTA, R.J. BOOCK et al. 1998. Role of ferrous iron chelator 2,2′-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage. J. Neurosurg. 88: 298-303.
73. KRANC, K.R., G.J. PYNE, L. TAO et al. 2000. Oxidative degradation of bilirubin produces vasoactive compounds. Eur. J. Biochem. 267: 7094-7101.
74. CLARK, J.F., M. REILLY & F.R. SHARP. 2002. Oxidation of bilirubin produces compounds that cause prolonged vasospasm of rat cerebral vessels: a contributor to sub-arachnoid hemorrhage-induced vasospasm. J. Cereb. Blood Flow Metab. 22: 472-478.
75. SUZUKI, H., K. KANAMARU, H. TSUNODA et al. 1999. Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J. Clin. Invest. 104: 59-66.
76. SUZUKI, H., K. KANAMARU, H. TSUNODA et al. 2001. The functional significance of heme oxygenase-1 gene induction in a rat vasospasm model. Acta Neurochir. Suppl. 77: 89-91.
77. ONO, S., T. KOMURO & R.L. MACDONALD. 2002. Heme oxygenase-1 gene therapy for prevention of vasospasm in rats. J. Neurosurg. 96: 1094-1102.
78. SCHWARTZ, S.M. 2001. A protective player in the vascular response to injury. Nat. Med. 7: 656-657.
79. WINESTONE, J.S., C. BONNER & C.W. LEFFLER. 2003. Carbon monoxide as an attenuator of vasoconstriction in piglet cerebral arterioles. Exp. Biol. Med. (Maywood) 228: 46-50.
80. WAGENER, F.A., A. EGGERT, O.C. BOERMAN et al. 2001. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 98: 1802-1811.
81. WAGENER, F.A., H.D. VOLK, D. WILLIS et al. 2003. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol. Rev. 55: 551-571.
82. GRACA-SOUZA, A.V., M.A. ARRUDA, M.S. DE FREITAS et al. 2002. Neutrophil activation by heme: implications for inflammatory processes. Blood 99: 4160-4165.
83. JENEY, V., J. BALLA, A. YACHIE et al. 2002. Pro-oxidant and cytotoxic effects of circulating heme. Blood 100: 879-887.
84. MOSLEY, K., D.E. WEMBRIDGE, V. CATTELL et al. 1998. Heme oxygenase is induced in nephrotoxic nephritis and hemin, a stimulator of heme oxygenase synthesis, ameliorates disease. Kidney Int. 53: 672-678.
85. ANDERSON, K.E. 2003. Approaches to treatment and prevention of human porphyrias. In The Porphyrin Handbook: Medical Aspects of Porphyrias, pp. 247-284. Elsevier. Amsterdam/New York.
86. TAKIZAWA, S., H. HIRABAYASHI, K. MATSUSHIMA et al. 1998. Induction of heme oxygenase protein protects neurons in cortex and striatum, but not in hippocampus, against transient forebrain ischemia. J. Cereb. Blood Flow Metab. 18: 559-569.
87. KITAMURA, Y., Y. ISHIDA, K. TAKATA et al. 2003. Hyperbilirubinemia protects against focal ischemia in rats. J. Neurosci. Res. 71: 544-550.
88. LIU, Y., B. ZHU, L. LUO et al. 2001. Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis. Neuroreport 12: 1841-1845.
89. LIU, Y., B. ZHU, X. WANG et al. 2003. Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis, J. Neuroimmunol. 139: 27-35.
90. CHAKRABARTY, A., M.R. EMERSON & S.M. LEVINE. 2003. Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis. Mult. Scler. 9: 372-381.
91. ZHANG, X., P. SHAN, L.E. OTTERBEIN et al. 2003. Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J. Biol. Chem. 278: 1248-1258.
92. RYTER, S.W. & R.M. TYRRELL. 2000. The heme synthesis and degradation pathways: role in oxidant sensitivity - heme oxygenase has both pro-and antioxidant properties. Free Radical Biol. Med. 28: 289-309.
93. IMAI, K., T. AIMOTO, M. SATO et al. 1990. Antioxidative effect of several porphyrins on lipid peroxidation in rat liver homogenates. Chem. Pharm. Bull. (Tokyo) 38: 258-260.
94. PATEL, M. & B.J. DAY. 1999. Metalloporphyrin class of therapeutic catalytic antioxidants. Trends Pharmacol. Sci. 20: 359-364.
95. WINTERBOURN, C.C. 1990. Oxidative reactions of hemoglobin. Methods Enzymol. 186: 265-272.